Bharat Serums and Vaccines partners with National Chemical Laboratory, Pune

June 13, 2022 | Monday | News

The tie-up focuses on the evaluation of certain recombinant cell line technologies

Image Credit: Shutterstock

Image Credit: Shutterstock

Mumbai-based Bharat Serums and Vaccines has partnered with the National Chemical Laboratory (NCL), Pune, a constituent laboratory of the Council of Scientific and Industrial Research (CSIR), Government of India.

This collaboration primarily focuses on the evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV.

The technology involves using CRISPR/Cas9 techniques to perform specific modifications of mammalian cell lines to achieve certain desired product quality attributes.

Sanjiv Navangul, MD and CEO, BSV said, “Through this collaboration, we are delighted to tap some of the best research minds in the country  to help us bring innovative treatments and cures for patients in India and the world.”

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy